AIM ImmunoTech Inc.
AIM
$1.21
$0.021.26%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 112.00K | 121.00K | 146.00K | 170.00K | 190.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 112.00K | 121.00K | 146.00K | 170.00K | 190.00K |
| Cost of Revenue | 95.00K | 35.00K | 33.00K | 31.00K | 36.00K |
| Gross Profit | 17.00K | 86.00K | 113.00K | 139.00K | 154.00K |
| SG&A Expenses | 10.26M | 11.54M | 12.64M | 13.90M | 20.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.68M | 16.73M | 17.80M | 19.94M | 28.11M |
| Operating Income | -14.57M | -16.61M | -17.66M | -19.77M | -27.92M |
| Income Before Tax | -15.75M | -16.17M | -15.21M | -17.32M | -23.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.75 | -16.17 | -15.21 | -17.32 | -23.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.75M | -16.17M | -15.21M | -17.32M | -23.93M |
| EBIT | -14.57M | -16.61M | -17.66M | -19.77M | -27.92M |
| EBITDA | -14.34M | -16.37M | -17.41M | -19.53M | -27.68M |
| EPS Basic | -19.82 | -24.66 | -24.45 | -30.94 | -47.33 |
| Normalized Basic EPS | -12.22 | -15.54 | -15.32 | -19.23 | -30.17 |
| EPS Diluted | -19.82 | -24.66 | -24.45 | -30.94 | -47.33 |
| Normalized Diluted EPS | -12.22 | -15.54 | -15.32 | -19.23 | -30.17 |
| Average Basic Shares Outstanding | 4.20M | 2.68M | 2.45M | 2.24M | 2.09M |
| Average Diluted Shares Outstanding | 4.20M | 2.68M | 2.45M | 2.24M | 2.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |